The Office of Management and Budget's (OMB) recent proposal to transform federal financial assistance guidelines into binding government-wide regulations has sparked widespread public backlash. Analysis of tens of thousands of comments reveals 94% opposition, reflecting deep concerns over increased political control of research funding.
- 94% of public comments oppose OMB's new federal funding rule
- Proposal shifts grant oversight to political appointees, risking scientific review integrity
- Grassroots activism drives opposition more than coordinated form-letter campaigns
What happened
On May 29, 2026, the White House Office of Management and Budget proposed a sweeping revision to 2 CFR Part 200, the Uniform Guidance governing federal financial assistance. The update aims to make these guidelines binding regulations and consolidate authority within OMB, particularly by instituting mandatory political pre-issuance reviews of discretionary awards and expanding agency powers to terminate grants and limit foreign collaborations.
This rule targets over $1 trillion distributed annually to entities including state and local governments, universities, nonprofits, and research institutes. Around $150 billion of this funding supports research and development efforts critical to US science and technology advancement, making the proposal's impact far-reaching across multiple sectors reliant on federal support.
Why it matters
The proposed changes threaten to politicize the federal funding process by allowing political appointees to intervene in the awarding and continuation of grants, undermining the peer-review system fundamental to scientific research integrity. Experts argue this risks stifling innovation and eroding trust in government-supported research funding mechanisms.
The scientific community's vocal opposition, including major societies and academic leaders, highlights concerns that the proposal circumvents Congressional intent. The new rule could transform federal research funding from an expert-driven endeavor into a tool for enforcing executive policy priorities, potentially reducing the effectiveness and independence of vital research programs.
What to watch next
As public commentary continues to pour in—already exceeding 50,000 submissions with the majority opposing the rule—the OMB and the Biden administration face mounting pressure to reconsider or revise the proposal. The volume and nature of opposition emphasize grassroots mobilization over coordinated form-letter campaigns, signaling broad-based public discontent.
Stakeholders across science, academia, and public policy will be monitoring regulatory developments closely to assess if political oversight provisions are modified or rolled back. Congressional responses and potential legislative actions may also emerge as key arenas for influencing the final scope and implementation of these financial assistance rules.